GlassScriptPhysician profile
Haley B Clark
NPI 1326417023
$2,139.61
in general payments reported to CMS, 2019-2025
22 companies · $14.42 in 2025
The $14.42 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $607 · 2022: $698 · 2023: $721 · 2024: $98.96 · 2025: $14.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $622.54 | 2021-2024 | |
| Amgen INC. | $280.53 | 2021-2024 | Repatha, Otezla |
| Lilly USA, LLC | $141.37 | 2021-2023 | Jardiance, Mounjaro, Reyvow |
| Bayer Healthcare Pharmaceuticals INC. | $140.08 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $130.36 | 2022 | |
| Agile Therapeutics, INC. | $103.81 | 2021-2023 | Twirla |
| Axsome Therapeutics, INC. | $85.61 | 2023-2025 | Auvelity, Sunosi |
| Teva Pharmaceuticals USA, INC. | $82.31 | 2022-2024 | Austedo Xr |
| Glaxosmithkline, LLC. | $79.86 | 2021-2023 | Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $77.78 | 2021 | |
| Hologic Sales and Service, LLC | $66.51 | 2022 | |
| Pfizer INC. | $57.14 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $54.86 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $53.41 | 2022 | |
| Scilex Pharmaceuticals INC. | $35.91 | 2023-2024 | Ztlido |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $31.05 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.05 | 2023 | Trintellix |
| Agios Pharmaceuticals, INC. | $15.99 | 2022 | |
| Mayne Pharma Commercial LLC | $15.83 | 2021 | |
| Currax Pharmaceuticals LLC | $12.32 | 2021 | |
| Ironwood Pharmaceuticals, INC | $12.22 | 2022 | |
| Radius Health, INC. | $11.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.